Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | INMT | O95050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1447816 | 0.70 | MAPT (0.45) | MAPTTDP1SMN1; SMN2ALDH1A1ERN1 | |
| SCHEMBL8692422 | 0.67 | MAPT (0.42) | MAPTTDP1SMN1; SMN2ALDH1A1ERN1 | |
| SCHEMBL5711878 | 0.64 | CHRNB2 (0.38) | SMN1; SMN2 | |
| SCHEMBL28222341 | 0.64 | MAPT (0.44) | MAPTTDP1SMN1; SMN2ALDH1A1ERN1 | |
| SCHEMBL7213681 | 0.63 | MAPT (0.39) | MAPTTDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4638899 | 0.63 | MAPT (0.40) | MAPTTDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL9051653 | 0.63 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL4153725 | 0.63 | MAPT (0.61) | MAPTTDP1SMN1; SMN2ALDH1A1ERN1 | |
| SCHEMBL4189196 | 0.62 | SLC18A3 (0.35) | MAPTINMT | |
| SCHEMBL17555020 | 0.62 | INMT (0.31) | INMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3313397-B1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | MERCK SHARP & DOHME (US) | 2020-11-25 | — | — | EP | claimed |
| US-8163728-B2 | Pyrazoles | HOFFMANN-LA ROCHE INC. (US) | 2012-04-24 | — | — | US | disclosed |
| EP-2427459-A1 | ISOXAZOLE-THIAZOLE DERIVATIVES AS GABA A RECEPTOR INVERSE AGONISTS FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| EP-2427455-A1 | ISOXAZOLE-PYRAZOLE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| EP-2427458-A1 | ISOXAZOLE-PYRIDAZINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| EP-2427456-A1 | ISOXAZOLE-PYRIDINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| US-20120000533-A1 | PHOTOELECTRIC CONVERSION DEVICE COMPRISING HYDROXAMIC ACID OR A SALT THEREOF AS ADDITIVE AND PROCESS FOR PRODUCING SAME | BASF SE (DE) | 2012-01-05 | — | — | US | disclosed |
| EP-1082010-A1 | FUNGICIDE MIXTURES BASED ON TRIPLE OXIME ETHER DERIVATIVES AND ADDITIONAL FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999048369-A1 | FUNGICIDE MIXTURES BASED ON TRIPLE OXIME ETHER DERIVATIVES AND ADDITIONAL FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-30 | — | — | WO | disclosed |